CD8A and cancer: ROS and NO produce the byproduct peroxynitrite, which disrupts the conjugation of the TCR component CD8 with major histocompatibility complex molecules on cancer cell surfaces, thereby reducing the cytotoxic activity of CD8+ CTLs [28,35].